|
SHMT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84260000002379E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55984999999914E-05 |
| Normal-vs-Stage2 |
1.261230E-01 |
| Normal-vs-Stage3 |
1.4655000002417E-07 |
| Normal-vs-Stage4 |
3.44460000001323E-06 |
| Stage1-vs-Stage2 |
1.189350E-01 |
| Stage1-vs-Stage3 |
1.999610E-01 |
| Stage1-vs-Stage4 |
1.769010E-01 |
| Stage2-vs-Stage3 |
3.036500E-02 |
| Stage2-vs-Stage4 |
2.761700E-02 |
| Stage3-vs-Stage4 |
6.938000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.81219999999738E-05 |
| Normal-vs-AfricanAmerican |
1.445930E-04 |
| Normal-vs-Asian |
1.61900999999798E-05 |
| Caucasian-vs-AfricanAmerican |
2.955800E-01 |
| Caucasian-vs-Asian |
2.601000E-01 |
| AfricanAmerican-vs-Asian |
7.113200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.954000E-04 |
| Normal-vs-Female |
7.17990000009827E-07 |
| Male-vs-Female |
3.719000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.71303999999539E-05 |
| Normal-vs-Age(41-60Yrs) |
1.600190E-04 |
| Normal-vs-Age(61-80Yrs) |
1.36350000001784E-06 |
| Normal-vs-Age(81-100Yrs) |
1.161010E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.709200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.586600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.270800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.904800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.922760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.922200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.001700E-02 |
| Classical-VS-Follicular |
8.044600E-01 |
| Classical-VS-Other |
6.328200E-01 |
| Classical-VS-Normal |
2.29809999999775E-05 |
| Tall-VS-Follicular |
9.813600E-02 |
| Tall-VS-Other |
1.797990E-01 |
| Tall-VS-Normal |
1.54226999999896E-05 |
| Follicular-VS-Other |
7.127600E-01 |
| Follicular-VS-Normal |
7.203800E-04 |
| Other-VS-Normal |
2.048400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61910999999515E-05 |
| Normal-vs-N1 |
4.23810000005354E-06 |
| N0-vs-N1 |
3.062800E-01 |
|
|
